Home > Publications database > A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. > print

001     131766
005     20240229105011.0
024 7 _ |a 10.1002/ijc.31145
|2 doi
024 7 _ |a pmid:29114882
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:31015752
|2 altmetric
037 _ _ |a DKFZ-2018-00063
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Barrdahl, Myrto
|0 0000-0003-4661-0763
|b 0
|e First author
245 _ _ |a A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.
260 _ _ |a Bognor Regis
|c 2018
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1521450290_11799
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a We assessed the association between 1,414 single nucleotide polymorphisms (SNPs) in genes involved in synthesis and metabolism of steroid hormones and insulin-like growth factor 1, and risk of breast cancer in situ (BCIS), with the aim of determining whether any of these were disease specific. This was carried out using 1,062 BCIS cases and 10,126 controls as well as 6,113 invasive breast cancer cases from the Breast and Prostate Cancer Cohort Consortium (BPC3). Three SNPs showed at least one nominally significant association in homozygous minor versus homozygous major models. ACVR2A-rs2382112 (ORhom  = 3.05, 95%CI = 1.72-5.44, Phom  = 1.47 × 10-4 ), MAST2-rs12124649 (ORhom  = 1.73, 95% CI =1.18-2.54, Phom  = 5.24 × 10-3 ), and INSR-rs10500204 (ORhom  = 1.96, 95% CI = 1.44-2.67, Phom =1.68 × 10-5 ) were associated with increased risk of BCIS; however, only the latter association was significant after correcting for multiple testing. Furthermore, INSR-rs10500204 was more strongly associated with the risk of BCIS than invasive disease in case-only analyses using the homozygous minor versus homozygous major model (ORhom  = 1.78, 95% CI = 1.30-2.44, Phom  = 3.23 × 10-4 ). The SNP INSR-rs10500204 is located in an intron of the INSR gene and is likely to affect binding of the promyelocytic leukemia (PML) protein. The PML gene is known as a tumor suppressor and growth regulator in cancer. However, it is not clear on what pathway the A-allele of rs10500204 could operate to influence the binding of the protein. Hence, functional studies are warranted to investigate this further.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Canzian, Federico
|0 0000-0002-4261-4583
|b 1
700 1 _ |a Gaudet, Mia M
|b 2
700 1 _ |a Gapstur, Susan M
|b 3
700 1 _ |a Trichopoulou, Antonia
|b 4
700 1 _ |a Tsilidis, Kostas
|b 5
700 1 _ |a van Gils, Carla H
|b 6
700 1 _ |a Borgquist, Signe
|0 0000-0001-7938-8893
|b 7
700 1 _ |a Weiderpass, Elisabete
|b 8
700 1 _ |a Khaw, Kay-Tee
|b 9
700 1 _ |a Giles, Graham G
|b 10
700 1 _ |a Milne, Roger L
|b 11
700 1 _ |a Le Marchand, Loic
|b 12
700 1 _ |a Haiman, Christopher
|b 13
700 1 _ |a Lindström, Sara
|b 14
700 1 _ |a Kraft, Peter
|b 15
700 1 _ |a Hunter, David J
|b 16
700 1 _ |a Ziegler, Regina
|b 17
700 1 _ |a Chanock, Stephen J
|b 18
700 1 _ |a Yang, Xiaohong R
|b 19
700 1 _ |a Buring, Julie E
|b 20
700 1 _ |a Lee, I-Min
|b 21
700 1 _ |a Kaaks, Rudolf
|0 0000-0003-3751-3929
|b 22
700 1 _ |a Campa, Daniele
|0 0000-0003-3220-9944
|b 23
773 _ _ |a 10.1002/ijc.31145
|g Vol. 142, no. 6, p. 1182 - 1188
|0 PERI:(DE-600)1474822-8
|n 6
|p 1182 - 1188
|t International journal of cancer
|v 142
|y 2018
|x 0020-7136
909 C O |o oai:inrepo02.dkfz.de:131766
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 0000-0003-4661-0763
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 0000-0002-4261-4583
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 0000-0003-3751-3929
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2015
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l Genomische Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21